New Scientist on MSN
'Weaponised' CAR T-cell therapy shows promise against solid tumours
So far, immune cells that have been engineered to kill cancers, known as CAR T-cells, haven’t worked well against solid ...
Medpage Today on MSN
Novel T-Cell Therapy Promising in Tough-to-Treat Eye Cancer
Among 16 patients with this difficult-to-treat tumor "with few treatment options," the confirmed overall response rate (ORR) ...
The ability of immune cells—particularly CD8+ T cells—to launch a rapid burst of proliferation inside tumors is key to the ...
MedPage Today on MSN
Who Knew? Autoimmunity Might Actually Benefit Some Cancer Patients
Some 68% of patients with autoimmune disease had "major" side effects from CAR-T therapy for myeloma, lymphoma, or leukemia, ...
Triple-negative breast cancer is one of the most aggressive cancers. The name tells the story: It lacks the three main ...
In 2015, Bluestone led a small clinical trial to isolate and grow Tregs from diabetes patients and then reinfuse the cells ...
AZoLifeSciences on MSN
Cracking the Code of T Cell Expansion Inside Tumors ...
The ability of immune cells-particularly CD8+ T cells-to launch a rapid burst of proliferation inside tumors is key to the ...
News-Medical.Net on MSN
Researchers uncover TRAT1's central role in T helper cell function
Researchers at the Medical University of Vienna have taken a closer look at a previously largely unknown component of the ...
The Nobel Prize in Medicine was awarded on Monday to three scientists for discovering how a particular kind of cell can stop the body's immune system from attacking itself.- The immune system is your ...
A pan-immunotherapy biomarker predicts and reactivates CD8⁺ T cell expansion, offering new insight into treatment response.
Liberate Bio’s CAR-M cell therapy almost completely depleted B-cells in a nonhuman primate study, the company said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback